Compound search：Set keywords and then click SEARCH.
category = @02s
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 06451 |  | Cyclic(-NH-PEG14-) | 91,200/0.1mg | >90% | 0 |
| 06452 |  | Cyclic(-NH-PEG13-) | 80,700/0.1mg | >90% | 0 |
| 06507 |  | Cyclic(-NH-PEG12-) | 80,700/0.1mg | >90% | 0 |
| 06506 |  | Cyclic(-NH-PEG11-) | 80,700/0.1mg | >90% | 0 |
| 06457 |  | Cyclic(-PEG4-N-)-CO-PEG11-COOH | 67,300/0.1mg | >95% | 13.3 |
| 06505 |  | Cyclic(-NH-PEG10-) | 80,700/0.1mg | >90% | 0 |
| 06504 |  | Cyclic(-NH-PEG9-) | 80,700/0.1mg | >90% | 0 |
| 06503 |  | Cyclic(-NH-PEG8-) | 80,700/0.1mg | >90% | 0 |
| 06502 |  | Cyclic(-NH-PEG7-) | 80,700/0.1mg | >90% | 0 |
| 06501 |  | Cyclic(-NH-PEG6-) | 80,700/0.1mg | >90% | 0 |
| 06376 |  | Cyclic(-NH-PEG5-) | 79,400/0.9mg | >90% | 6.0 |
| 03689 |  | tert-Butyl (2S)-2-[(1R,2R)-3-[[(1S)-1-benzyl-2-oxo-2-[2-(2-prop-2-ynoxyethoxy)ethylamino]ethyl]amino]-1-methoxy-2-methyl-3-oxo-propyl]pyrrolidine-1-carboxylate | 119,600/0.1mg | >95% | 206.2 |
| 06385 |  | Cyclic(-NH-PEG4-) | inquire | >90% | 0 |
| 03156 |  | Mono-6-(NH2-PEG3-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 491.9 |
| 06388 |  | Cyclic(-NH-PEG3-) | 96,800/0.1mg | >90% | 0 |
| 01133 |  | OH-Et-NH-PEG3-NH-Et-OH | 67,300/75mg | >95% | 2,530.0 |
| 05407 |  | Mono-6-(NH2-PEG3-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 81.5 |
| 03855 |  | Peptide intermediate | 119,600/0.1mg | >95% | 2.0 |
| 05406 |  | Mono-6-(NH2-PEG3-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 50.0 |
| 01950 |  | Trt-PEG3-NH-PEG2-OH | 64,600/10mg | >95% | 230.0 |
| 05474 |  | Mono-6-(N3-PEG3-NH)-beta-cyclodextrin | 65,700/0.6mg | >90% | 0.2 |
| 02648 |  | Mono-2-(NH2-PEG3-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 35.5 |
| 04983 |  | Mono-6-(NH2-C2-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 261.0 |
| 05497 |  | tert-butyl (2S)-2-(2-hydroxypropyl)pyrrolidine-1-carboxylate | 64,600/10mg | >95% | 86.9 |
| 04974 |  | 2-Chloro-5-(ethylaminomethyl)pyridine | 64,600/75mg | >95% | 1,000.0 |
| 01491 |  | tylosin N-desmethyl | 70,700/0.1mg | >95% | 20.7 |
| 03193 |  | Heptakis-6-(NH2-C2-NH)-beta-cyclodextrin | 83,400/0.3mg | >90% | 29.5 |
| 00532 |  | Cholesteryl 3beta-carboxyamidoethylene-N-hydroxyethylamine | 64,600/10mg | >95% | 27.6 |
| 02334 |  | Fmoc-D-beta-Pro-OH | inquire | >95% | 0 |
| 05217 |  | Mono-6-(NH2-C4-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 86.2 |
| 02459 |  | Mono-2-(NH2-C2-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 46.2 |
| 05967 |  | 2-[4-(1,1-dioxo-6'-piperazin-1-yl-spiro[2,1-ramda--benzoxathiole-3,9'-xanthene]-3'-yl)piperazin-1-yl]acetic acid | 64,600/0.1mg | >95% | 0 |
| 04847 |  | 3',6'-di(piperazin-1-yl)spiro[2,1-ramda-benzoxathiole-3,9'-xanthene] 1,1-dioxide | 64,600/0.7mg | >90% | 16.0 |
| 05486 |  | Mono-6-(N3-C4-NH)-beta-cyclodextrin | 63,100/0.6mg | >90% | 0.1 |
| 04940 |  | Boc-Me-L-Glu(OMe)-OH | inquire | >95% | 3.8 |
| 05522 |  | Boc-AA2-OH | 70,000/0.1mg | >95% | 0.1 |
| 03513 |  | Boc-NMe-L-Asp(OMe)-OtBu | 64,600/75mg | >95% | 0 |
| 00075 |  | Boc-Piperazine | inquire | >95% | 542.6 |
| 00182 |  | 1-Boc-1H-pyrrole-2-carboxylic acid | inquire | >95% | 0 |
| 07921 |  | 6,7-dimethoxy-1-(4-methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline | 64,600/100mg | >95% | 5,223.3 |
| 04792 |  | Mono-6-(NH2-C6-NH)-beta-cyclodextrin | inquire | >95% | 60.4 |
| 04793 |  | Mono-6-(NHTrt-C6-NH)-beta-cyclodextrin | 67,300/0.5mg | >95% | 1.4 |
| 05215 |  | Mono-6-(NH2-C2-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 78.9 |
| 05846 |  | Doxycycline N-monodesmethyl | 63,300/0.9mg | >95% | 38.3 |
| 03516 |  | NMe-L-Leu(4-OH)-OH | 70,700/0.1mg | >90% | 0 |
| 05212 |  | Mono-6-(NH2-C4-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 921.7 |
| 02464 |  | Mono-2-(NH2-C3-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 61.5 |
| 05216 |  | Mono-6-(NH2-C3-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 89.8 |
| 03515 |  | Me-L-Asp(OMe)-OH | 72,000/50mg | >95% | 90.0 |
| 03223 |  | Heptakis-6-(OH-C2-NH)-beta-cyclodextrin | 70,300/2.5mg | <80% | 85.7 |
| 05210 |  | Mono-6-(NH2-C2-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 62.8 |
| 03207 |  | beta-cyclodextrin pentakis-(6-NH-Et-NH2 deoxy)-6-6'-ethylenediamino dideoxy | 82,100/0.9mg | >80% | 78.9 |
| 02463 |  | Mono-2-(NH2-C2-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 68.7 |
| 01853 |  | N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide | 65,200/7.5mg | >95% | 246.0 |
| 05685 |  | Per-6-NH-allyl-gamma-cyclodextrin | 65,200/7.5mg | >90% | 46.3 |
| 05680 |  | Mono-6-NH-allyl-beta-cyclodextrin | 67,300/75mg | >90% | 175.0 |
| 03517 |  | Fmoc-NMe-L-Leu(4-OH)-OH | 64,600/0.5mg | >95% | 11.9 |
| 01917 |  | 2-[(2S)-1-Fmoc-pyrrolidin-2-yl]-2-oxo-ethanediazonium | inquire | >95% | 0 |
| 05211 |  | Mono-6-(NH2-C3-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 56.9 |
| 02650 |  | Mono-2-(NH2-C3-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 10.7 |
| 03153 |  | Mono-6-(NH2-C4-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 562.5 |
| 05679 |  | Mono-6-NH-allyl-alpha-cyclodextrin | 68,300/25mg | >90% | 165.2 |
| 04784 |  | Mono-6-(NHTrt-C3-NH)-beta-cyclodextrin | 64,600/0.2mg | >95% | 4.9 |
| 04856 |  | N3',N6'-dimethyl-N3',N6'-bis[2-(methylamino)ethyl]-1,1-dioxo-spiro[2,1-ramda-benzoxathiole-3,9'-xanthene]-3',6'-diamine | 64,600/0.7mg | >95% | 7.9 |
| 02473 |  | Mono-2-(NH2-C4-NH)-beta-cyclodextrin | 68,300/25mg | >90% | 56.6 |
| 02704 |  | Mono-2-(NH2-C4-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 15.4 |
| 05684 |  | Per-6-NH-allyl-beta-cyclodextrin | 65,200/7.5mg | >90% | 60.8 |
| 00521 |  | 1-Benzyl-pyrrolidine-2-carboxylic acid (2-benzoyl-phenyl)-amide | 67,600/25mg | >95% | 0 |
| 02461 |  | Mono-2-(NH2-C4-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 1,651.8 |
| 00120 |  | N-Bn-L-Proline | inquire | >95% | 0.1 |
| 02649 |  | Mono-2-(NH2-C2-NH)-gamma-cyclodextrin | 68,300/25mg | >90% | 21.9 |
| 00912 |  | (4-Acetylamino-butyl)-(3-acetylamino-propyl)-carbamic acid tert-butyl ester | 64,600/100mg | >95% | 1,650.0 |
| 02576 |  | 9H-fluoren-9-ylmethyl 4-nitrosopiperazine-1-carboxylate | 72,000/5mg | >95% | 629.9 |
| 02460 |  | Mono-2-(NH2-C3-NH)-alpha-cyclodextrin | 68,300/25mg | >90% | 81.7 |
